Post-transplant malignancies in alcoholic liver disease

Area of Science:

• Hepatology
• Oncology
• Transplantation Medicine

Background:

• Post-transplant malignancy is a growing concern for liver transplant (LT) recipients.
• Approximately 30% of deaths a decade after LT are attributed to de novo malignancies.
• Risk factors include immunosuppression, patient age, alcoholic liver disease (ALD), primary sclerosing cholangitis, smoking, and viral infections.

Purpose of the Study:

• To evaluate the relationship between liver transplantation and post-transplant malignancy.
• To investigate the specific risks of malignancy in patients transplanted for alcoholic liver disease (ALD).

Main Methods:

• Literature review and evidence synthesis.
• Analysis of existing data on risk factors and outcomes in liver transplant recipients.
• Focus on patients with alcoholic cirrhosis.

Main Results:

• De novo malignancies account for a substantial portion of late mortality post-LT.
• Patients transplanted for ALD exhibit an elevated risk for oropharyngeal and lung cancers.
• Immunosuppression, age, ALD, smoking, and viral infections are identified risk factors.

Conclusions:

• Post-transplant malignancy is a critical factor in liver transplant outcomes.
• Lifestyle modifications, including alcohol and tobacco abstinence, are crucial for risk reduction.
• Optimizing immunosuppression is vital for mitigating malignancy risk.